Niu Liaoran, Yang Wanli, Duan Lili, Wang Xiaoqian, Li Yiding, Xu Chengchao, Liu Chao, Zhang Yujie, Zhou Wei, Liu Jinqiang, Zhao Qingchuan, Hong Liu, Fan Daiming
State Key Laboratory of Cancer Biology and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, Shaanxi Province, China.
94719 Military Hospital, Ji'an 343700, Jiangxi Province, China.
Mol Ther Nucleic Acids. 2020 Oct 22;23:42-54. doi: 10.1016/j.omtn.2020.10.030. eCollection 2021 Mar 5.
Colorectal cancer (CRC), ranking as the third commonest cancer, leads to extremely high rates of mortality. Metastasis is the major cause of poor outcome in CRC. When metastasis occurs, 5-year survival rates of patients decrease sharply, and strategies to enhance a patient's lifetime seem limited. MicroRNAs (miRNAs) are evolutionarily conserved small non-coding RNAs that are significantly involved in manipulation of CRC malignant phenotypes, including proliferation, invasion, and metastasis. To date, accumulating studies have revealed the mechanisms and functions of certain miRNAs in CRC metastasis. However, there is no systematic discussion about the biological implications and clinical potential (diagnostic role, prognostic role, and targeted therapy potential) of metastasis-related miRNAs in CRC. This review mainly summarizes the recent advances of miRNA-mediated metastasis in CRC. We also discuss the clinical values of metastasis-related miRNAs as potential biomarkers or therapeutic targets in CRC. Moreover, we envisage the future orientation and challenges in translating these findings into clinical applications.
结直肠癌(CRC)是第三大常见癌症,死亡率极高。转移是CRC预后不良的主要原因。当发生转移时,患者的5年生存率急剧下降,延长患者生存期的策略似乎有限。微小RNA(miRNA)是进化上保守的小非编码RNA,它们显著参与调控CRC的恶性表型,包括增殖、侵袭和转移。迄今为止,越来越多的研究揭示了某些miRNA在CRC转移中的机制和功能。然而,关于CRC中转移相关miRNA的生物学意义和临床潜力(诊断作用、预后作用和靶向治疗潜力)尚无系统讨论。本综述主要总结了miRNA介导的CRC转移的最新进展。我们还讨论了转移相关miRNA作为CRC潜在生物标志物或治疗靶点的临床价值。此外,我们设想了将这些发现转化为临床应用的未来方向和挑战。